SPMay 16
Prognostic Value of Lung Ultrasound Biomarkers for Readmission Risk in Congestive Heart Failure: A Pilot Data-Driven AnalysisJana Armouti, Laura Hutchins, Jacob Duplantis et al.
Hospital readmission within 30 days of discharge is a leading driver of morbidity, mortality, and avoidable healthcare expenditure in congestive heart failure (CHF). Current clinical risk stratification tools rely primarily on non-imaging data and exhibit limited predictive performance. Point-of-care lung ultrasound (LUS) offers a sensitive, noninvasive window into the pulmonary congestion that characterizes CHF decompensation, yet its prognostic utility for readmission prediction remains largely unexplored. We present a pilot feasibility study, the first systematic machine learning study using B-mode LUS acquired during hospitalization to predict 30-day CHF readmission. Quantitative spatiotemporal embeddings are extracted from a pretrained Temporal Shift Module (TSM) ResNet-18 encoder, and interpretable biomarker features are separately evaluated. Through structured ablations over lung view, temporal representation, multi-view fusion, and cross-lung augmentation, we identify the key imaging factors driving readmission risk. Our findings reveal that (1) dependent lower-lung regions (Left-3, Right-3) carry the strongest prognostic signal, consistent with their greater susceptibility to hydrostatic congestion; (2) temporal difference features between sequential examinations substantially outperform single-timepoint representations, highlighting the importance of capturing disease trajectory; and (3) multi-view feature concatenation yields the best overall performance, with our top MLP model achieving an F1 score of 0.80 (95% CI: 0.62-0.96). Biomarker analysis further reveals that pleural-line abnormalities, including breaks and indentations, are as informative as the canonical A-line and B-line markers. These results support POCUS-derived biomarkers as practical, interpretable tools for noninvasive CHF risk stratification.
CVNov 8, 2025
DiLO: Disentangled Latent Optimization for Learning Shape and Deformation in Grouped Deforming 3D ObjectsMostofa Rafid Uddin, Jana Armouti, Umong Sain et al.
In this work, we propose a disentangled latent optimization-based method for parameterizing grouped deforming 3D objects into shape and deformation factors in an unsupervised manner. Our approach involves the joint optimization of a generator network along with the shape and deformation factors, supported by specific regularization techniques. For efficient amortized inference of disentangled shape and deformation codes, we train two order-invariant PoinNet-based encoder networks in the second stage of our method. We demonstrate several significant downstream applications of our method, including unsupervised deformation transfer, deformation classification, and explainability analysis. Extensive experiments conducted on 3D human, animal, and facial expression datasets demonstrate that our simple approach is highly effective in these downstream tasks, comparable or superior to existing methods with much higher complexity.
IVNov 2, 2024
LEARNER: Contrastive Pretraining for Learning Fine-Grained Patient Progression from Coarse Inter-Patient LabelsJana Armouti, Nikhil Madaan, Rohan Panda et al. · cmu
Predicting whether a treatment leads to meaningful improvement is a central challenge in personalized medicine, particularly when disease progression manifests as subtle visual changes over time. While data-driven deep learning (DL) offers a promising route to automate such predictions, acquiring large-scale longitudinal data for each individual patient remains impractical. To address this limitation, we explore whether inter-patient variability can serve as a proxy for learning intra-patient progression. We propose LEARNER, a contrastive pretraining framework that leverages coarsely labeled inter-patient data to learn fine-grained, patient-specific representations. Using lung ultrasound (LUS) and brain MRI datasets, we demonstrate that contrastive objectives trained on coarse inter-patient differences enable models to capture subtle intra-patient changes associated with treatment response. Across both modalities, our approach improves downstream classification accuracy and F1-score compared to standard MSE pretraining, highlighting the potential of inter-patient contrastive learning for individualized outcome prediction.